ARDC Research Link Australia Research Link Australia   BETA Research
Link
Australia
  • ARDC Newsletter Subscribe
  • Contact Us
  • Home
  • About
  • Feedback
  • Explore Collaborations
2026 ARDC Annual Survey is now open!

The Australian Research Data Commons (ARDC) invites you to participate in a short survey about your interaction with the ARDC and use of our national research infrastructure and services. The survey will take approximately 5 minutes and is anonymous. It’s open to anyone who uses our digital research infrastructure services including Reasearch Link Australia.

We will use the information you provide to improve the national research infrastructure and services we deliver and to report on user satisfaction to the Australian Government’s National Collaborative Research Infrastructure Strategy (NCRIS) program.

Please take a few minutes to provide your input. The survey closes COB Friday 29 May 2026.

Complete the 5 min survey now by clicking on the link below.

Take Survey Now

Thank you.

  • Researcher
  • Funded Activity
  • Organisation
  • Researcher
  • Funded Activity
  • Organisation
  • Researcher
  • Funded Activity
  • Organisation

Need help searching? View our Search Guide.

Advanced Search

Current Selection
Country : Australia
Research Topic : retinal vascular sign
Clear All
Filter by Field of Research
Cardiology (incl. Cardiovascular Diseases) (4)
Endocrinology (3)
Respiratory Diseases (3)
Developmental Genetics (incl. Sex Determination) (2)
Psychiatry (2)
Allergy (1)
Biochemistry and Cell Biology (1)
Biochemistry and Cell Biology not elsewhere classified (1)
Biological Psychology (Neuropsychology, Psychopharmacology, Physiological Psychology) (1)
Cell Development, Proliferation and Death (1)
Clinical Sciences not elsewhere classified (1)
Epidemiology (1)
Exercise Physiology (1)
Gene and Molecular Therapy (1)
Genetic Development (Incl. Sex Determination) (1)
Medical Biotechnology not elsewhere classified (1)
Medical and Health Sciences not elsewhere classified (1)
Obstetrics and Gynaecology (1)
Ophthalmology (1)
Opthalmology And Vision Science (1)
Protein Trafficking (1)
Systems Physiology (1)
Vision Science (1)
Filter by Socio-Economic Objective
Search did not return any results.
Filter by Funding Provider
National Health and Medical Research Council (35)
Filter by Status
Closed (35)
Filter by Scheme
Project Grants (19)
NHMRC Project Grants (11)
Centres of Research Excellence (1)
Development Grants (1)
Programs (1)
Research Fellowships (1)
Targeted Calls (1)
Filter by Country
Australia (35)
Filter by Australian State/Territory
NSW (11)
VIC (10)
SA (8)
WA (3)
QLD (2)
ACT (1)
TAS (1)
  • Researchers (0)
  • Funded Activities (35)
  • Organisations (0)
  • Funded Activity

    The Role Of Microglia In Early Diabetic Retinopathy

    Funder
    National Health and Medical Research Council
    Funding Amount
    $665,582.00
    Summary
    Diabetic retinopathy is one of the most feared complications of diabetes. This project will examine the role that retinal immune cells called microglia have in causing early changes in the vasculature. We will examine whether diabetes changes the way neurons communicate with blood vessels, opening up a possible treatment target that could prevent the progression to more advanced disease.
    More information
    Funded Activity

    Role Of Epigenomic Changes In Conferring Hyperglycemic Memory

    Funder
    National Health and Medical Research Council
    Funding Amount
    $636,146.00
    Summary
    The major burden of type I diabetes remains its vascular complications including diabetes-accelerated athersclerosis. Despite improved glucose control, diabetic individuals develop complications as a result of prior poor glycemic control. Although the development and progression of these diabetic complications is strongly associated with mean levels of glucose, recent studies suggest that the deleterious effects of early exposure to high levels of glucose persist for years even after treatment h .... The major burden of type I diabetes remains its vascular complications including diabetes-accelerated athersclerosis. Despite improved glucose control, diabetic individuals develop complications as a result of prior poor glycemic control. Although the development and progression of these diabetic complications is strongly associated with mean levels of glucose, recent studies suggest that the deleterious effects of early exposure to high levels of glucose persist for years even after treatment has returned glucose levels towards normal.
    Read more Read less
    More information
    Funded Activity

    Regulation Of VEGFR Trafficking And Signal Transduction By The Ubiquitin Ligase Nedd4

    Funder
    National Health and Medical Research Council
    Funding Amount
    $388,347.00
    Summary
    Our recent work has discovered that the Nedd4 gene is crucial for the growth and development of blood vessels and lymphatic vessels. Our data suggest that Nedd4 controls vessel growth by regulating the levels and signalling activity of the key vascular growth factor receptors VEGFR-2 and VEGFR-3. The goals of this proposal are to define precisely how Nedd4-1 regulates the activity of these receptors and how VEGFR signalling could be better targeted to treat vascular disorders.
    More information
    Funded Activity

    Development Of A High Acuity, Diamond Retinal Prosthesis

    Funder
    National Health and Medical Research Council
    Funding Amount
    $1,010,214.00
    Summary
    Over recent years our team has developed a retinal implant to restore sight to people with certain types of blindness. With 256 independently controllable electrodes this device is among the most sophisticated in the world. We aim to conduct experiments to demonstrate that our device can provide improved better visual acuity than the world leaders with a view to developing a competitive commercial medical technology.
    More information
    Funded Activity

    Self-destructing CRISPR-constructs For Targeted Genome Editing In The Retina.

    Funder
    National Health and Medical Research Council
    Funding Amount
    $679,926.00
    Summary
    Despite the identification of specific mutations causing many inherited retinal dystrophies, all of these conditions are currently untreatable. We have established gene-editing techniques and have developed a novel mouse model, which will serve as a robust platform for testing different techniques of gene editing in the retina. No other group in the world is known to be using this platform for gene editing and our work will expedite the clinical translation of this technology.
    More information
    Funded Activity

    A Fibroin-based Prosthetic Bruch's Membrane For The Treatment Of Age-related Macular Degeneration

    Funder
    National Health and Medical Research Council
    Funding Amount
    $538,080.00
    Summary
    Our aim is to develop a new therapy for the treatment of patients with age-related macular degeneration (AMD), a leading cause of blindness in our ageing population. The novelty of our therapy resides in using a protein derived from silk fibers (fibroin), to rebuild a healthy barrier between the outermost layer of the retina and adjacent blood vessels. We expect that the findings from this study will eventually lead to better outcomes for patients with AMD.
    More information
    Funded Activity

    An Extended Follow-up Of Stroke Patients For Cognitive Impairment And Neuropsychiatric Disorders: Sydney Stroke Study

    Funder
    National Health and Medical Research Council
    Funding Amount
    $321,800.00
    Summary
    Vascular Dementia (VaD) is the second most common cause of dementia after Alzheimer's disease. In fact, it may be a preventable cause of dementia. Yet it has been relatively neglected by researchers until the last decade, which has seen an upsurge of interest in this disorder. There is no consensus on the criteria for dementia. The profile of early cognitive impairment due to vascular factors is still poorly understood, and the longitudinal course of VaD as defined by modern criteria has not bee .... Vascular Dementia (VaD) is the second most common cause of dementia after Alzheimer's disease. In fact, it may be a preventable cause of dementia. Yet it has been relatively neglected by researchers until the last decade, which has seen an upsurge of interest in this disorder. There is no consensus on the criteria for dementia. The profile of early cognitive impairment due to vascular factors is still poorly understood, and the longitudinal course of VaD as defined by modern criteria has not been studied. There have been few studies of the progressive changes in MRI in patients with cerebrovascular disease. The overlap of VaD and Alzheimer's disease (AD) remains a problem for taxonomists and clinicians. One approach to the study of VaD is to examine a high risk group of subjects longitudinally to determine the early features, the risk factors and progressive changes. With this in mind, we began studying a cohort of stroke patients who are at high risk of VaD, in 1997-1999, and are following them longitudinally. The follow-up is now in its third year, and three neuropsychological assessments and two MRI-MRS scans have been performed. We propose to extend the follow-up to 5 years, with repeat neuropsychiatric, neuropsychological and MRI-MRS investigations, and wherever possible to necropsy, to determine the nature of vascular pathology that underlies cognitive impairment. Our cohort of stroke patients is arguably the most comprehensively assessed such cohorts internationally, and presents an excellent opportunity for a long-term follow-up study.
    Read more Read less
    More information
    Funded Activity

    Role For Zinc And ZIP2 In The Action Of Nitric Oxide And In Vascular Protection Against Cigarette Smoke And Cardiovascular Disease

    Funder
    National Health and Medical Research Council
    Funding Amount
    $685,941.00
    Summary
    The NO/cGMP signalling pathway, which is central to cardiovascular physiology and protection against disease, is only fully effective when there are adequate levels of zinc in the vascular endothelium. This is especially important where zinc stores are depleted (elderly, smokers, diabetics and kidney disease). There is an urgent clinical need to implement strategies to monitor vascular Zn status. This application will explore the underlying science and translate these to the clinic.
    More information
    Funded Activity

    Defining The Role Of The Ubiquitin Protein Ligase Nedd4 In Vascular Development.

    Funder
    National Health and Medical Research Council
    Funding Amount
    $702,166.00
    Summary
    Blood and lymphatic vessels are vital components of the cardiovascular system. Abnormalities in the growth and development of these vessels are associated with human disorders including cancer and cardiovascular disease. The focus of this application is to characterise the role of the ubiquitin protein ligase Nedd4 in vascular development, with the aim of identifying targets to which novel therapeutics for the treatment of blood and lymphatic vascular diseases could be generated.
    More information
    Funded Activity

    The Role Of Dicarbonyl-derived AGEs And RAGE In Diabetes Associated Atherosclerosis

    Funder
    National Health and Medical Research Council
    Funding Amount
    $470,617.00
    Summary
    Based on our pilot data we postulate that glucose derived molecules such as methylglyoxal (MGO) have effects on inflammation and oxidative stress leading to accelerated atherosclerosis in diabetes. Our studies aim to identify novel treatments which block these effects thus leading to superior protection and prevention of atherosclerosis in diabetes.
    More information

    Showing 1-10 of 35 Funded Activites

    • 1
    • 2
    • 3
    Advanced Search

    Advanced search on the Researcher index.

    Advanced search on the Funded Activity index.

    Advanced search on the Organisation index.

    National Collaborative Research Infrastructure Strategy

    The Australian Research Data Commons is enabled by NCRIS.

    ARDC CONNECT NEWSLETTER

    Subscribe to the ARDC Connect Newsletter to keep up-to-date with the latest digital research news, events, resources, career opportunities and more.

    Subscribe

    Quick Links

    • Home
    • About Research Link Australia
    • Product Roadmap
    • Documentation
    • Disclaimer
    • Contact ARDC

    We acknowledge and celebrate the First Australians on whose traditional lands we live and work, and we pay our respects to Elders past, present and emerging.

    Copyright © ARDC. ACN 633 798 857 Terms and Conditions Privacy Policy Accessibility Statement
    Top
    Quick Feedback